• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 3. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 4. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

Comprehensive Overview of 1-(3-Chlorophenyl)-N-Methylmethanamine Hydrobromide (CAS No. 1185292-73-2)

1-(3-Chlorophenyl)-N-methylmethanamine hydrobromide (CAS No. 1185292-73-2) is a chemically synthesized compound that has garnered significant attention in pharmaceutical and biochemical research. This compound, often referred to by its systematic name, belongs to the class of arylalkylamines, which are known for their diverse applications in medicinal chemistry. The presence of a 3-chlorophenyl group and a methylamine moiety makes it a versatile intermediate for further derivatization.

In recent years, the demand for 1-(3-chlorophenyl)-N-methylmethanamine hydrobromide has increased due to its potential role in the development of novel therapeutic agents. Researchers are particularly interested in its structural features, which may contribute to binding affinity with specific biological targets. The hydrobromide salt form enhances its solubility, making it more suitable for formulation studies. This aligns with the growing trend of optimizing drug candidates for improved bioavailability.

One of the most frequently searched questions related to this compound is: "What are the applications of 1-(3-chlorophenyl)-N-methylmethanamine hydrobromide in drug discovery?" The answer lies in its potential as a building block for central nervous system (CNS) active compounds. Its structural similarity to other pharmacologically active amines suggests possible utility in designing neurotransmitter modulators or receptor ligands. However, rigorous preclinical studies are necessary to validate these hypotheses.

Another hot topic in the scientific community is the synthetic routes for 1-(3-chlorophenyl)-N-methylmethanamine hydrobromide. Optimizing its synthesis to achieve higher yields and purity is a key focus area. Recent advancements in green chemistry have also prompted researchers to explore environmentally friendly methods for producing this compound. This resonates with the broader industry shift toward sustainable practices.

The compound's physicochemical properties, such as melting point, solubility, and stability, are critical for its handling and storage. These parameters are often queried in academic and industrial settings, emphasizing the need for accurate data. For instance, the hydrobromide salt form typically exhibits better crystalline properties compared to its free base, which is advantageous for characterization and formulation.

From a regulatory perspective, 1-(3-chlorophenyl)-N-methylmethanamine hydrobromide is not classified as a controlled substance, but its use must comply with local and international guidelines. Researchers are advised to consult relevant material safety data sheets (MSDS) and conduct thorough risk assessments before handling. This precautionary approach aligns with the increasing emphasis on laboratory safety and compliance.

In summary, 1-(3-chlorophenyl)-N-methylmethanamine hydrobromide (CAS No. 1185292-73-2) represents a promising candidate for further exploration in pharmaceutical research. Its unique structural attributes and potential applications make it a subject of ongoing investigation. As the scientific community continues to uncover its capabilities, this compound may play a pivotal role in the development of next-generation therapeutics.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)